These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6905671)

  • 1. Clearance and metabolism of circulating pancreatic proelastase in the rat.
    Largman C; Ray SB; Brodrick JW; Geokas MC
    Am J Physiol; 1980 Dec; 239(6):G504-10. PubMed ID: 6905671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of circulating anionic and cationic pancreatic trypsinogens in the rat.
    Brodrick JW; Largman C; Geokas MC; O'Rourke M; Ray SB
    Am J Physiol; 1980 Dec; 239(6):G511-5. PubMed ID: 7446744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a pancreatic proelastase 2-alpha 1-protease inhibitor complex in normal human plasma.
    Largman C; Brodrick JW; Geokas MC; Johnson JH; Fassett M
    Am J Physiol; 1980 Mar; 238(3):G177-82. PubMed ID: 6966139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human blood platelet elastase and proelastase. Activation of proelastase and release of elastase after ahesion of platelets to collagen.
    Legrand Y; Pignaud G; Caen JP
    Haemostasis; 1977; 6(3):180-9. PubMed ID: 885380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular form of pancreatic elastase 1 in human plasma.
    Hayakawa S; Hayakawa T; Kondo T; Shibata T; Naruse S
    Int J Pancreatol; 1992 Feb; 11(1):1-7. PubMed ID: 1583352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the kidney in the plasma clearance of angiotensinogen in the rat: plasma clearance and tissue distribution of 125I-angiotensinogen.
    Yayama K; Yoshiya M; Takahashi K; Matsui T; Takano M; Okamoto H
    Life Sci; 1995; 57(19):1791-801. PubMed ID: 7475921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of pure human erythropoietin in the rat.
    Emmanouel DS; Goldwasser E; Katz AI
    Am J Physiol; 1984 Jul; 247(1 Pt 2):F168-76. PubMed ID: 6742201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of circulating renin in conscious rats.
    Kim S; Iwao H; Nakamura N; Ikemoto F; Yamamoto K
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E136-46. PubMed ID: 3544862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance and metabolism of 125I-labeled tonin in the rat.
    Morris BJ; Cheng ES
    Endocrinology; 1982 Nov; 111(5):1462-8. PubMed ID: 6181985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of rat pancreatic elastase.
    Largman C
    Biochemistry; 1983 Aug; 22(16):3763-70. PubMed ID: 6555050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance and metabolism of glandular kallikrein in the rat.
    Rabito SF; Seto M; Maitra SR; Carretero OA
    Am J Physiol; 1985 Jun; 248(6 Pt 1):E664-8. PubMed ID: 3847263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic elastase in human serum. Determination by radioimmunoassay.
    Geokas MC; Brodrick JW; Johnson JH; Largman C
    J Biol Chem; 1977 Jan; 252(1):61-7. PubMed ID: 833129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma clearance and organ distribution of native and desialylated rat and human transcortin: species specificity.
    Hossner KL; Billiar RB
    Endocrinology; 1981 May; 108(5):1780-6. PubMed ID: 7215299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
    Arany E; Zabel P; Hill DJ
    Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreatic proelastase 2. Sequence of the activation peptide.
    Largman C; Brodrick JW; Geokas MC
    Biochim Biophys Acta; 1980 May; 623(1):208-12. PubMed ID: 6900509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of radioactive exocrine pancreatic proteins injected into the blood circulation of the rat. Tissue uptake and transepithelial excretion.
    Rohr G; Scheele G
    Gastroenterology; 1983 Nov; 85(5):991-1002. PubMed ID: 6618114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of serotonin on secretory and lysosomal enzyme activity in pancreatic tissue and the inhibitory properties of serum].
    Chernoiarova OD; Trubitsyna IE
    Biull Eksp Biol Med; 1981 Oct; 91(10):417-9. PubMed ID: 6914901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human blood platelet elastase and proelastase.
    Legrand Y; Pignaud G
    Pathol Biol (Paris); 1975 Sep; 23(7):546-9. PubMed ID: 1101157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin.
    Rucinski B; Knight LC; Niewiarowski S
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H800-7. PubMed ID: 3766757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.